Brain tumours: 3D experimental system to evaluate candidate drugs against glioma
A three-dimensional experimental system has been developed to study the response to drugs in low-grade…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Radiation therapy improves outcomes for ‘supermassive’ bile duct tumours
A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialised high-dose…
Poverty, access and outcomes: what’s driving worse survival in colorectal cancer?
Living in areas of persistent poverty is associated with poorer outcomes across multiple cancers—but the…
From concept to clinic: mRNA vaccines advance in oncology
A recent article published in JAMA explores the emerging role of mRNA vaccines as a…
New breast cancer trial explores omission of radiotherapy
Breast Cancer Trials’ new clinical breast cancer trial, named ROSALIE, aims to discover whether people…
Genetic discrimination ban paves the way for expansion of life-saving DNA screening
A national legislative ban on life insurers discriminating against applicants based on genetic testing would…
The PBS Update: April 2026
PBS UPDATE SERIES 1 / EPISODE 2 The PBS Update Podcast: April 2026 Welcome to…
Culture, silence and safety: why oncology cannot afford to ignore its workforce
By Dr Dominique Lee Public trust in oncology relies on strong professional standards, transparent governance, and…
EU approval for pembrolizumab plus paclitaxel ± bevacizumab for adult PD-L1 platinum-resistant recurrent ovarian carcinoma
The European Commission has approved pembrolizumab plus paclitaxel plus or minus bevacizumab for the treatment…
Study of robotic bronchoscopy suggests it’s safer, faster path to diagnosing lung cancer
Most peripheral pulmonary lesions are benign, yet the malignant minority represents the leading cause of…